The Academy of Oncology Nurse & Patient Navigators (AONN+) is pleased to share that long-time member, and seasoned healthcare executive Rani Khetarpal, MBA, has been announced as President of its ...

Oral delivery of proteins and peptides has historically faced significant technical barriers due to the enzymatic degradation and poor permeability of macromolecules in the gastrointestinal (GI) tract ...

Research agreement is evaluating feasibility of applying Rani’s oral delivery technology to Chugai’s antibodies against ...

RANI READ THE FULL RANI RESEARCH REPORT On May 13 th Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) reported first quarter 2025 results. Year to date, Rani has updated investors on ProGen’s PG102 ...

Contract Revenue for the three months ended March 31, 2025 were $0.2 million and was attributable to evaluation services performed for a customer. There was no contract revenue for the same period in ...

Bleomycins are a family of glycopeptide antibiotics with antitumour activity. They are used clinically in combination chemotherapy against lymphomas, squamous-cell carcinomas and germ-cell tumours.

May 9, 2025 -- Allarity Therapeutics, Inc. ("Allarity” or the "Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib-a differentiated, dual PARP ...

HLS Therapeutics Inc. (HLS), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease, announces that it has entered into an ...

Senators Shelley Moore Capito, R-W.Va., and Jeanne Shaheen, D-N.H., reintroduced the Access to Prescription Digital Therapeutics (PDT) Act on Thursday to expand access to software-based treatments.

ATA Action, the advocacy arm of the American Telemedicine Association, is supporting a new bipartisan bill that could bring FDA-authorized prescription digital therapeutics (PDTs) under Medicare and ...